These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38346463)

  • 1. Determining reference ranges for lymphocyte proliferation responses to phytohemagglutinin and Bacillus Calmette-Guérin in Iranian children.
    Nourizadeh M; Sarrafzadeh SA; Shoormasti RS; Fazlollahi MR; Saghafi S; Badalzadeh M; Mirmoghtadaei M; Pourpak Z
    Clin Immunol; 2024 Apr; 261():109937. PubMed ID: 38346463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW.
    Ong RYL; Chan SB; Chew SJ; Liew WK; Thoon KC; Chong CY; Yung CF; Sng LH; Tan AM; Bhattacharyya R; Jamuar SS; Lim JY; Li J; Nadua KD; Kam KQ; Tan NW
    Int J Infect Dis; 2020 Aug; 97():117-125. PubMed ID: 32497805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
    Lee PP
    Ann Acad Med Singap; 2015 Aug; 44(8):297-301. PubMed ID: 26477962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review.
    Fekrvand S; Yazdani R; Olbrich P; Gennery A; Rosenzweig SD; Condino-Neto A; Azizi G; Rafiemanesh H; Hassanpour G; Rezaei N; Abolhassani H; Aghamohammadi A
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1371-1386. PubMed ID: 32006723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacillus Calmette-Guérin vaccine-related complications in children in Oman.
    Al Waili B; Al Mufarajii N; Al Hashmi S; Al Ajmi A; Al Sukaiti N
    Ann Saudi Med; 2021; 41(1):24-30. PubMed ID: 33550906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated bacille Calmette-Guérin in Iranian children with severe combined immunodeficiency.
    Sadeghi-Shabestari M; Rezaei N
    Int J Infect Dis; 2009 Nov; 13(6):e420-3. PubMed ID: 19403320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eight years of follow-up experience in children with mendelian susceptibility to mycobacterial disease and review of the literature.
    Azarsiz E; Karaca N; Karaca E; Aksu G; Genel F; Gulez N; Ozen S; Kutukculer N
    Asian Pac J Allergy Immunol; 2023 Dec; 41(4):372-378. PubMed ID: 33638623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Sarrafzadeh SA; Nourizadeh M; Mahloojirad M; Fazlollahi MR; Shokouhi Shoormasti R; Badalzadeh M; Deswarte C; Casanova JL; Pourpak Z; Bustamante J; Moin M
    J Clin Immunol; 2019 Apr; 39(3):287-297. PubMed ID: 30715640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.
    Ono R; Tsumura M; Shima S; Matsuda Y; Gotoh K; Miyata Y; Yoto Y; Tomomasa D; Utsumi T; Ohnishi H; Kato Z; Ishiwada N; Ishikawa A; Wada T; Uhara H; Nishikomori R; Hasegawa D; Okada S; Kanegane H
    J Clin Immunol; 2023 Feb; 43(2):466-478. PubMed ID: 36336768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R
    J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Early Bacillus Calmette-Guerin Vaccination of Pediatric Severe Combined Immunodeficiency Patients on the Outcome of Hematopoietic Stem Cell Transplantation Using a Reduced-Intensity Conditioning Regimen.
    Jafari L; Hamidieh AA; Behfar M; Karamlou Y; Shamsipour M; Mohseni R; Farajifard H; Salajegheh P
    Transplant Cell Ther; 2023 Mar; 29(3):188.e1-188.e8. PubMed ID: 36539079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG Infection in Patients With Inborn Errors of Immunity Receiving the Russian BCG Strain.
    Laberko A; Yukhacheva D; Kan N; Roppelt A; Mukhina A; Rodina Y; Pershin D; Cheng A; Lionakis MS; Solopova G; Kadnikova O; Mushkin A; Novichkova G; Shcherbina A
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1797-1804.e7. PubMed ID: 35470098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial prophylaxis regarding Bacillus Calmette-Guérin -associated complications in children with primary immunodeficiency.
    Ozsezen B; Yalçın E; Ademhan Tural D; Sunman B; Nayır Buyuksahin H; Guzelkas İ; Alboga D; Aytekin ES; Esenboga S; Emiralioglu N; Cagdas D; Doğru D; Özçelik U; Tezcan I; Kiper N
    Respir Med; 2022; 200():106919. PubMed ID: 35779416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of BCG on concanavalin A-induced suppressor cell activity and lymphocyte stimulation in stage I melanoma.
    Pehamberger H; Knapp W
    J Invest Dermatol; 1981 Jun; 76(6):502-5. PubMed ID: 6453908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
    Peñafiel Vicuña AK; Yamazaki Nakashimada M; León Lara X; Mendieta Flores E; Nuñez Núñez ME; Lona-Reyes JC; Hernández Nieto L; Ramírez Vázquez MG; Barroso Santos J; López Iñiguez Á; González Y; Torres M; Lezana Fernández JL; Román Montes CM; Medina-Torres EA; González Serrano E; Bustamante Ogando JC; Lugo Reyes S; Zavaleta Martínez O; Staines Boone AT; Venegas Montoya E; Aguilar Gómez NE; Soudeé C; Jouanguy E; Puel A; Boisson-Dupuis S; Pedraza Sánchez S; Casanova JL; Espinosa Rosales F; Espinosa Padilla S; Bustamante J; Blancas Galicia L
    J Clin Immunol; 2023 Jan; 43(1):123-135. PubMed ID: 36044171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID).
    Barkai G; Somech R; Stauber T; Barziali A; Greenberger S
    Infect Dis (Lond); 2019 Aug; 51(8):585-592. PubMed ID: 31204539
    [No Abstract]   [Full Text] [Related]  

  • 18. Disseminated bacillus Calmette-Guérin infections in patients with primary immunodeficiencies.
    Abramowsky C; Gonzalez B; Sorensen RU
    Am J Clin Pathol; 1993 Jul; 100(1):52-6. PubMed ID: 8346737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assistance of next-generation sequencing for diagnosis of disseminated Bacillus Calmette-Guerin disease with X-SCID in an infant: a case report and literature review.
    Zhang H; Liao Y; Zhu Z; Liu H; Li D; Wang S
    Front Cell Infect Microbiol; 2024; 14():1341236. PubMed ID: 38410723
    [No Abstract]   [Full Text] [Related]  

  • 20. Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.
    Secanella-Fandos S; Noguera-Ortega E; Olivares F; Luquin M; Julián E
    J Urol; 2014 May; 191(5):1422-8. PubMed ID: 24333111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.